| All patients | Non-recurrent | Recurrent | p value |
---|---|---|---|---|
Age (n) | 32 | 23 | 9 | Â |
 Median, IQR | 83, 79–85 | 83, 79–85 | 82, 81–85 | 0.916 |
Gender | ||||
 Female | 13 | 9 | 4 | 1.000 |
 Male | 19 | 14 | 5 |  |
Histology | ||||
 Ad | 24 | 18 | 6 | 0.655 |
 Non-Ad | 8 | 5 | 3 |  |
Morphology | ||||
 Solid/part solid | 26 | 17 | 9 | 0.150 |
 GGO | 6 | 6 | 0 |  |
Dose | ||||
 40 Gy (PTV D95) | 23 | 17 | 6 | 0.685 |
 48 Gy (isocenter) | 9 | 6 | 3 |  |
Tumor diameter | 23.0, 17.0–32.3 | 21.0, 15.0–27.5 | 28.0, 26.0–35.0 | 0.013 |
FDG SUVmax | 7.89, 2.00–10.1 | 6.02, 1.81–8.94 | 9.73, 8.46–13.2 | 0.005 |
FDG MTV | 6.62, 1.15–10.0 | 6.21, 3.71–9.50 | 8.19, 3.52–10.8 | 0.586 |
FMISO SUVmax | 1.50, 0.88–2.05 | 1.15, 0.82–1.59 | 2.21, 1.90–2.74 | < 0.001 |
FMISO TMR | 1.11, 0.72–1.80 | 0.83, 0.68–1.19 | 2.22, 1.79–2.44 | < 0.001 |
FMISO TBR | 0.91, 0.63–1.41 | 0.75, 0.60–1.04 | 1.70, 1.37–1.80 | < 0.001 |